Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

BACITRACIN-NEOMYCIN-POLYMYXIN

BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Standard Dose
400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BACITRACIN-NEOMYCIN-POLYMYXIN is listed in Drugs@FDA under application 062167 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM Sponsor PHARMADERM Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview BACITRACIN-NEOMYCIN-POLYMYXIN is listed in Drugs@FDA under application 062167 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM Sponsor PHARMADERM Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
BACITRACIN-NEOMYCIN-POLYMYXIN (BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) | Drug Monograph | MedicHelpline